Amneal is releasing Crexont (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease.

and distribution of generic and specialty pharmaceutical products, has seen a notable insider transaction trend. Amneal Pharmaceuticals ( NASDAQ:AMRX ) Second Quarter 2024 Results Key Financial ...

Nasdaq-listed Amneal Pharmaceuticals, which already operates multiple manufacturing facilities in Gujarat, is further ...

Amneal will also be granted a license to commercialize Metsera's products in select emerging markets, including India and certain countries in Southeast Asia, Africa and the Middle East.

AvKARE revenues increased 33%, driven by continued expansion across its channels due to new products. Guidance: Amneal ...

Amneal will also be granted a license to commercialize Metsera’s products in select emerging markets, including India and certain countries in Southeast Asia, Africa and the Middle East.

As part of the deal, Amneal will receive a license to market Metsera’s products in select emerging markets like India and certain Southeast Asian countries should Metsera’s drugs eventually ...

Metsera, a biotech focused on obesity drugs that came out of stealth this year, said Tuesday that it is partnering with drug manufacturer Amneal Pharmaceuticals to produce injectable and oral ...

Amneal and Shilpa have received the Food and ... We look forward to bringing more branded oncology products to the market for providers while expanding access for patients,” said Sean McGowan ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

JP Morgan has recently raised Amneal Pharmaceuticals Inc (AMRX) stock to Neutral rating, as announced on September 6, 2024, according to Finviz. Earlier, on April 7, 2021, RBC Capital Mkts had resumed ...

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company, and Metsera, Inc. ("Metsera"), a clinical-stage biopharmaceutical company accelerating the ...